News
Archive
Finally, Graphene electronic devices available for all
Ventyx Biosciences reports clinical data for its NLRP3 inhibitor portfolio and provides pipeline updates at virtual investor event
NorthSea Therapeutics initiates Phase 2A trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD)
Resolve Therapeutics announces publication of Lupus clinical trial results
biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC
InvestEU in Belgium: EIB venture debt for bone therapy innovator Novadip
Back To NewsJanuary 31, 2018
January newsletter
Happy New Year to our extended Bright
V
olt family!
The new year is here and we want to share a couple of the exciting changes at BrightVolt from 2017. We will continue to hire and expand our capabilities in 2018 and deliver on our mission of providing the world’s thinnest, safest, most flexible thin film batteries and solutions!